TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 12706322

Group type: EXPERIMENTAL
Intervention: Enalapril (E)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 73
Study: 10627726

Group type: EXPERIMENTAL
Intervention: Hydroxyapatite coated femoral prostheses
Number of subjects: 55

Group type: COMPARATOR
Intervention: Nonhydroxyapatite coated femoral prostheses (Control)
Number of subjects: 55
Study: 7782428

Group type: EXPERIMENTAL
Intervention: 10,000 IU of HCG
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control values from the menstrual cycle prior to experiments
Number of subjects: 8
Study: 1851620

Group type: EXPERIMENTAL
Intervention: External radiation to the breast (50 Gy)
Number of subjects: 216

Group type: COMPARATOR
Intervention: Observation alone
Number of subjects: 216
Study: 6111525

Group type: EXPERIMENTAL
Intervention: 50 mg of atenolol (Tenormin) for 3 days
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Fenetyllinhydrochloride, diazepam, oxazepam, and alcohol
Number of subjects: 40
Study: 6499553

Group type: EXPERIMENTAL
Intervention: Postoperative chest percussion with postural drainage (CPT)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Standard postoperative respiratory care
Number of subjects: 53
Study: 30447668

Group type: EXPERIMENTAL
Intervention: Intramuscular cholecalciferol (vitamin D)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Not applicable (control group of non-ECMO patients)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: ECMO patients
Number of subjects: 24

Group type: COMPARATOR
Intervention: Non-ECMO patients
Number of subjects: 24
Study: 26829509

Group type: EXPERIMENTAL
Intervention: 1 g of intravenous tranexamic acid
Number of subjects: 332

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 332
Study: 24688085

Group type: EXPERIMENTAL
Intervention: beta‐hydroxy‐beta‐methylbutyrate/arginine/glutamine supplement (Group A)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (Group B)
Number of subjects: 40
Study: 22296842

Group type: EXPERIMENTAL
Intervention: Acrylic toric IOL (Acrysof)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Silicone toric IOL (Staar)
Number of subjects: 50
Study: 20350039

Group type: EXPERIMENTAL
Intervention: Strong African American Families (SAAF) program
Number of subjects: 667

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 667
Study: 18551818

Group type: EXPERIMENTAL
Intervention: Cefepime (2 g, single i.v. administration)
Number of subjects: 209

Group type: COMPARATOR
Intervention: Ceftriaxone (2 g, single i.v. administration)
Number of subjects: 209
Study: 16502720

Group type: EXPERIMENTAL
Intervention: Prolonged transthoracic microelectrostimulation
Number of subjects: 0
Study: 11972726

Group type: EXPERIMENTAL
Intervention: Paroxetine
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Problem-solving therapy
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Cognitive behavioral therapy
Number of subjects: 29

Group type: COMPARATOR
Intervention: Amitriptyline
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Serotonin-selective reuptake inhibitors (SSRIs)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Venlafaxine
Number of subjects: 29

Group type: COMPARATOR
Intervention: Tricyclic antidepressants
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Sertraline and Fluoxetine
Number of subjects: 29
Study: 10876473

Group type: EXPERIMENTAL
Intervention: Psychosocial education sessions (7 sessions, 20 minutes each, 2 days a week for 4.5 weeks)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 10
Study: 8956464

Group type: EXPERIMENTAL
Intervention: Pilot needle with Y-shaped hub and side-port for guide wire insertion
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Central approach via the internal jugular vein
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Supraclavicular approach via the junction of the internal jugular vein and subclavian vein
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Infraclavicular approach via the subclavian vein
Number of subjects: 60
Study: 1941428

Group type: EXPERIMENTAL
Intervention: Multicomponent hospital program designed to prepare children for emergency room visits
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Medical examination in an emergency room (Phase 2)
Number of subjects: 148

Group type: COMPARATOR
Intervention: Control group (children who did not attend the program)
Number of subjects: 148
Study: 6283801

Group type: EXPERIMENTAL
Intervention: Lunelax (fibre-containing bulk-purgative)
Number of subjects: 12
Study: 31764009

Group type: EXPERIMENTAL
Intervention: Aneroid sphygmomanometer (AnS)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Mercury sphygmomanometer (HgS)
Number of subjects: 300
Study: 31848158

Group type: EXPERIMENTAL
Intervention: Intervention group 1 (IG1): personal training with SMS recommendations
Number of subjects: 137

Group type: EXPERIMENTAL
Intervention: Intervention group 2 (IG2): e-learning training without SMS
Number of subjects: 137

Group type: COMPARATOR
Intervention: Control group (CG): regular information letters, online training after 1 year
Number of subjects: 137
Study: 27522310

Group type: EXPERIMENTAL
Intervention: Nonrebreather mask with flush rate oxygen (NRB-Flush)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Bag-valve-mask device with oxygen at 15 L/min (BVM-15)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Nonrebreather mask with oxygen at 15 L/min (NRB-15)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Simple mask with flush rate oxygen
Number of subjects: 26
Study: 25365396

Group type: EXPERIMENTAL
Intervention: Single-item teacher ratings of student readiness
Number of subjects: 350
Study: 23609526

Group type: EXPERIMENTAL
Intervention: Anodal tDCS
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Cathodal tDCS
Number of subjects: 40

Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 40
Study: 21560012

Group type: EXPERIMENTAL
Intervention: Sling procedure and self‐catheterization in SISTEr
Number of subjects: 1252

Group type: EXPERIMENTAL
Intervention: Baseline recurrent UTI (rUTI; ≥3 in 12 months)
Number of subjects: 1252

Group type: EXPERIMENTAL
Intervention: PVR > 100 cc at 12 months
Number of subjects: 1252

Group type: EXPERIMENTAL
Intervention: Successful surgery (negative cough stress test) at 1 year in women with pre‐operative rUTI
Number of subjects: 1252

Group type: EXPERIMENTAL
Intervention: Baseline rUTI
Number of subjects: 1252
Study: 18691360

Group type: EXPERIMENTAL
Intervention: TIB restriction (n = 22)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control (n = 18)
Number of subjects: 42
Study: 16437344

Group type: EXPERIMENTAL
Intervention: Sulbactam/ampicillin
Number of subjects: 419

Group type: COMPARATOR
Intervention: Cefazolin
Number of subjects: 419

Group type: EXPERIMENTAL
Intervention: Not applicable
Number of subjects: 419
Study: 12766654

Group type: EXPERIMENTAL
Intervention: Bupivacaine 0.1% with 5 microg/ml fentanyl
Number of subjects: 555

Group type: COMPARATOR
Intervention: Ropivacaine 0.1% with 5 microg/ml fentanyl
Number of subjects: 555

Group type: EXPERIMENTAL
Intervention: Bupivacaine
Number of subjects: 555

Group type: COMPARATOR
Intervention: Ropivacaine
Number of subjects: 555
Study: 11463605

Group type: COMPARATOR
Intervention: Placebo (0.9% saline)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: UTP 20 mg
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: UTP 100 mg
Number of subjects: 15
Study: 9006398

Group type: EXPERIMENTAL
Intervention: Divalproex sodium
Number of subjects: 179

Group type: EXPERIMENTAL
Intervention: Lithium carbonate
Number of subjects: 179

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 179
Study: 7962342

Group type: EXPERIMENTAL
Intervention: LPL exon 2 variant
Number of subjects: 39

Group type: COMPARATOR
Intervention: Coding region mutations of the LPL gene
Number of subjects: 39
Study: 3118327

Group type: EXPERIMENTAL
Intervention: Beta-galactosidase pretreatment of milk
Number of subjects: 0

Group type: COMPARATOR
Intervention: Lactose solution (35 g)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Glucose + galactose solution (17.5 + 17.5 g)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Native skimmed milk
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Milk pretreated with beta-galactosidase
Number of subjects: 0
Study: 31205105

Group type: EXPERIMENTAL
Intervention: Trimetazidine (TMZ) 35 mg orally twice a day for 3 months
Number of subjects: 58

Group type: COMPARATOR
Intervention: Conventional treatments for angina
Number of subjects: 58
Study: 27783092

Group type: EXPERIMENTAL
Intervention: Dense cataract group (visual acuity worse than 20/200)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (visual acuity better than 20/200)
Number of subjects: 0
Study: 26241948

Group type: EXPERIMENTAL
Intervention: Peru-15 vaccine with buffer
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo (buffer only)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Peru-15 vaccine
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 23252875

Group type: EXPERIMENTAL
Intervention: Cardiac resynchronization therapy with defibrillator (CRT-D)
Number of subjects: 1820
Study: 21196104

Group type: EXPERIMENTAL
Intervention: Fluticasone/formoterol (500/20 μg, b.i.d.)
Number of subjects: 620
Study: 18487565

Group type: EXPERIMENTAL
Intervention: Induction chemotherapy with carboplatin (AUC, 6) and paclitaxel (225 mg/m(2)); followed by weekly carboplatin (AUC, 2) and paclitaxel (45 mg/m(2)) with 74 Gy of TRT
Number of subjects: 69

Group type: COMPARATOR
Intervention: Induction chemotherapy with carboplatin (AUC, 5) and gemcitabine (1,000 mg/m(2)); followed by biweekly gemcitabine (35 mg/m(2)) with 74 Gy of TRT
Number of subjects: 69
Study: 16562348

Group type: EXPERIMENTAL
Intervention: Mobile mammography intervention
Number of subjects: 499
Study: 12708902

Group type: EXPERIMENTAL
Intervention: Clivarin (low-molecular-weight heparin) administered subcutaneously at a fixed daily dosage of 1750 U
Number of subjects: 1073

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1073
Study: 11027925

Group type: EXPERIMENTAL
Intervention: Fluoxetine
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study: 8884861

Group type: EXPERIMENTAL
Intervention: Ringer's acetate
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Dextran 70 (Macrodex)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Polygeline (Haemaccel)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Albumin 4%
Number of subjects: 40
Study: 1728634

Group type: EXPERIMENTAL
Intervention: Retinoic acid
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sodium lauryl sulfate
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cultured adult human keratinocytes treated with retinoic acid
Number of subjects: 0
Study: 4029877

Group type: EXPERIMENTAL
Intervention: 400 microgram of iodine
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: 150 microgram of L-thyroxine
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study: 30943515

Group type: EXPERIMENTAL
Intervention: pre‐OL‐HDF
Number of subjects: 38

Group type: COMPARATOR
Intervention: CHD
Number of subjects: 38
Study: 28205417

Group type: EXPERIMENTAL
Intervention: Slow tempo (84 bpm)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Fast tempo (112 bpm)
Number of subjects: 10
Study: 27604474

Group type: EXPERIMENTAL
Intervention: Early precut sphincterotomy
Number of subjects: 101

Group type: COMPARATOR
Intervention: Pancreatic duct stent placement
Number of subjects: 101
Study: 24578449

Group type: EXPERIMENTAL
Intervention: Perioperative glutamine administration
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control (no glutamine)
Number of subjects: 22
Study: 22581299

Group type: EXPERIMENTAL
Intervention: Transapical transcatheter aortic valve implantation (a‐TAVI)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Surgical aortic valve replacement (SAVR)
Number of subjects: 70
Study: 20220522

Group type: EXPERIMENTAL
Intervention: 1/12 reporting (time-sampled)
Number of subjects: 2

Group type: COMPARATOR
Intervention: 12/12 reporting (continuous-time)
Number of subjects: 2
Study: 18856077

Group type: EXPERIMENTAL
Intervention: Exercise intervention (minimum of three days a week for eight weeks)
Number of subjects: 0
Study: 16380702

Group type: EXPERIMENTAL
Intervention: Regular aerobic exercise on a stationary bicycle
Number of subjects: 43
Study: 14578687

Group type: EXPERIMENTAL
Intervention: Bryostatin-1 25 microg/m2 as a 1h infusion weekly for 3 weeks followed by a 1-week rest (Regimen I)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Bryostatin-1 120 microg/m2 as a 72 h continuous infusion every 2 weeks (Regimen II)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Both Regimen I and Regimen II
Number of subjects: 55
Study: 10474085

Group type: EXPERIMENTAL
Intervention: Acute normovolemic hemodilution (ANH)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Preoperative autologous blood donation (PAD)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: ANH for unilateral knee replacement
Number of subjects: 32

Group type: COMPARATOR
Intervention: PAD for unilateral knee replacement
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: ANH for bilateral/revision procedures
Number of subjects: 32

Group type: COMPARATOR
Intervention: PAD for bilateral/revision procedures
Number of subjects: 32
Study: 8598356

Group type: EXPERIMENTAL
Intervention: Bromodeoxyuridine labeling index (BrdUrd LI)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Radiation therapy
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Karnofsky performance score
Number of subjects: 200
Study: 8103770

Group type: EXPERIMENTAL
Intervention: Pyridostigmine (120 mg, orally, at -60 min) plus GHRH (1 microgram/kg, iv, at 0 min)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Arginine (30 g, iv, from 0-30 min) plus GHRH (1 microgram/kg, iv, at 0 min)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Normal subjects (control group)
Number of subjects: 24
Study: 3538986

Group type: EXPERIMENTAL
Intervention: Primary suture of the common bile duct
Number of subjects: 80

Group type: COMPARATOR
Intervention: T-tube drainage of the common bile duct
Number of subjects: 80
Study: 29518230

Group type: EXPERIMENTAL
Intervention: Mindfulness for Pain and Performance Enhancement (MPPE) - Acceptance and Commitment Therapy-based program; six sessions over 2 weeks.
Number of subjects: 373

Group type: COMPARATOR
Intervention: Standard treatment services (control group); physical therapy, medical interventions, and psychoeducational groups.
Number of subjects: 373
Study: 27542236

Group type: EXPERIMENTAL
Intervention: 150 grams of vitamin D3 enriched salmon (high D3+high K1) two times/week
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: 150 grams of vitamin D3 enriched salmon (low D3+high K1) two times/week
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: 150 grams of vitamin D3 enriched salmon (high D3+low K1) two times/week
Number of subjects: 122

Group type: COMPARATOR
Intervention: 800 IU vitamin D and 1000 mg calcium/day (tablet group)
Number of subjects: 122
Study: 24754891

Group type: EXPERIMENTAL
Intervention: Mammario-radial endoscopic group
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Aorto-radial endoscopic group
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Mammario-radial open surgery group
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Aorto-radial open surgery group
Number of subjects: 300

Group type: COMPARATOR
Intervention: All groups
Number of subjects: 300
Study: 22954508

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy (doxorubicin 75 mg/m², ifosfamide 5 g/m², lenograstim)
Number of subjects: 351

Group type: COMPARATOR
Intervention: Control group (no chemotherapy)
Number of subjects: 351

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy (doxorubicin, ifosfamide)
Number of subjects: 351
Study: 20384716

Group type: EXPERIMENTAL
Intervention: Study drug (new antiepileptic drugs)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 19025610

Group type: EXPERIMENTAL
Intervention: Sublingual sugar (SLS)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Intravenous 10% glucose (IVG)
Number of subjects: 23
Study: 15858602

Group type: EXPERIMENTAL
Intervention: L-carnitine (50 mumol/kg/day, intravenously until infants tolerated 16 ml/day of feeds)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: L-carnitine
Number of subjects: 63
Study: 14634414

Group type: EXPERIMENTAL
Intervention: Apomorphine hydrochloride 2 mg
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Apomorphine hydrochloride 3 mg
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Apomorphine hydrochloride (dose increased from 2 to 3 mg)
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Apomorphine hydrochloride (overall response)
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Adverse effects of apomorphine hydrochloride
Number of subjects: 107
Study: 10463681

Group type: EXPERIMENTAL
Intervention: Japanese encephalitis vaccine (inactivated, BIKEN), administered in two dosing regimens (days 0, 7, and either 14 or 30)
Number of subjects: 538

Group type: EXPERIMENTAL
Intervention: Japanese encephalitis vaccine (inactivated, BIKEN)
Number of subjects: 538
Study: 8020876

Group type: EXPERIMENTAL
Intervention: Platelet-aggregation factor inhibitor (single doses)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo (initial single-blind period)
Number of subjects: 12
Study: 2920630

Group type: EXPERIMENTAL
Intervention: Corrugated drain
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Corrugated plus Shirley sump drain
Number of subjects: 30

Group type: COMPARATOR
Intervention: Both drainage methods
Number of subjects: 30

Group type: COMPARATOR
Intervention: Higher than 12 cm anastomosis
Number of subjects: 30

Group type: COMPARATOR
Intervention: Coloanal anastomosis
Number of subjects: 30
Study: 1149486

Group type: EXPERIMENTAL
Intervention: Floctafenine
Number of subjects: 77

Group type: COMPARATOR
Intervention: Dextropropoxyphene
Number of subjects: 77

Group type: COMPARATOR
Intervention: Aspirin
Number of subjects: 77
Study: 31479396

Group type: EXPERIMENTAL
Intervention: Tension-Free Vaginal Tape
Number of subjects: 224

Group type: COMPARATOR
Intervention: Polyacrylamide Hydrogel
Number of subjects: 224
Study: 31340056

Group type: EXPERIMENTAL
Intervention: Prednisone
Number of subjects: 382

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 382

Group type: EXPERIMENTAL
Intervention: Prednisone (Physicians)
Number of subjects: 382

Group type: COMPARATOR
Intervention: Placebo (Physicians)
Number of subjects: 382

Group type: EXPERIMENTAL
Intervention: Hyperglycaemia occurrence
Number of subjects: 382

Group type: EXPERIMENTAL
Intervention: Time to clinical stability
Number of subjects: 382
Study: 29354914

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 60

Group type: COMPARATOR
Intervention: Moxibustion
Number of subjects: 60
Study: 26160250

Group type: EXPERIMENTAL
Intervention: Tamoxifen
Number of subjects: 74

Group type: COMPARATOR
Intervention: Aromatase Inhibitors (AI)
Number of subjects: 74
Study: 23238423

Group type: EXPERIMENTAL
Intervention: Mini‐VREM feedback (FB)
Number of subjects: 80
Study: 21988576

Group type: EXPERIMENTAL
Intervention: Motivational enhancement therapy (MET)
Number of subjects: 194

Group type: COMPARATOR
Intervention: Counseling as usual (CAU)
Number of subjects: 194
Study: 18243412

Group type: EXPERIMENTAL
Intervention: Active tDCS (anode right/cathode left)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Active tDCS (anode left/cathode right)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Active tDCS (both conditions)
Number of subjects: 23
Study: 16808776

Group type: EXPERIMENTAL
Intervention: Inpatient treatment
Number of subjects: 1889

Group type: EXPERIMENTAL
Intervention: PSI risk classes II and III
Number of subjects: 1889

Group type: EXPERIMENTAL
Intervention: Presence of medical or psychosocial contraindications to outpatient treatment
Number of subjects: 1889

Group type: EXPERIMENTAL
Intervention: Comorbid conditions not contained in the PSI (cognitive impairment, history of coronary artery disease, diabetes mellitus, pulmonary disease)
Number of subjects: 1889

Group type: EXPERIMENTAL
Intervention: Multilobar radiographic infiltrates
Number of subjects: 1889

Group type: EXPERIMENTAL
Intervention: Home therapy with oxygen, corticosteroids, or antibiotics before presentation
Number of subjects: 1889

Group type: EXPERIMENTAL
Intervention: No identifiable risk factors for hospitalization other than PSI risk class II or III
Number of subjects: 1889

Group type: EXPERIMENTAL
Intervention: Presence of one or more contraindications to outpatient treatment
Number of subjects: 1889

Group type: EXPERIMENTAL
Intervention: Treatment of low-risk patients in the outpatient setting
Number of subjects: 1889
Study: 12774577

Group type: EXPERIMENTAL
Intervention: Five-bevel needle for subcutaneous administration
Number of subjects: 0
Study: 11045835

Group type: EXPERIMENTAL
Intervention: Cutaneous application of soybean oil
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no cutaneous treatment)
Number of subjects: 60
Study: 9315170

Group type: EXPERIMENTAL
Intervention: Transcranial color Doppler sonography
Number of subjects: 12
Study: 7969673

Group type: EXPERIMENTAL
Intervention: Living related donor kidney transplant
Number of subjects: 8

Group type: COMPARATOR
Intervention: Normal subjects (control)
Number of subjects: 8
Study: 3304412

Group type: EXPERIMENTAL
Intervention: 40 mg methylprednisolone (Solumedrone Upjohn Limited) given intravenously immediately preoperatively
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 40 mg methylprednisolone
Number of subjects: 20
Study: 29945470

Group type: EXPERIMENTAL
Intervention: Habit-building intervention
Number of subjects: 94

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Self-report MVPA
Number of subjects: 94
Study: 28720592

Group type: EXPERIMENTAL
Intervention: Exercise training (20 weeks)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Nontraining (control group, n = 15)
Number of subjects: 60
Study: 26225845

Group type: EXPERIMENTAL
Intervention: 10Hz tACS
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: 20Hz tACS
Number of subjects: 26

Group type: COMPARATOR
Intervention: Sham tACS
Number of subjects: 26

Group type: COMPARATOR
Intervention: 35Hz tACS
Number of subjects: 26